IBRX - ImmunityBio, Inc.
9
-1.000 -11.111%
Share volume: 32,792,651
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$10.00
0.00
0.00%
Summary score
53%
Profitability
43%
Dept financing
43%
Liquidity
75%
Performance
60%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
26.22%
Return on assets
-20.96%
Return on sales
-119059.3%
Return on invested capital
-11.82%
Total debt ratio
240.51%
Debt ratio change over timeo
2.03%
Current Ratio
2.61%
Quick Ratio
2.49%
Cash Position Ratio
1.55%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-17%
Return on sales
-213.64%
Return on invested capital
0%
Total debt ratio
234.35%
Debt ratio change over timeo
0%
Current Ratio
4.3%
Quick Ratio
4.19%
Cash Position Ratio
1.61%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
13.32%
Return on sales
96.17%
Return on invested capital
0%
Total debt ratio
199.72%
Debt ratio change over time
0%
Current Ratio
5.1%
Quick Ratio
5.08%
Cash Position Ratio
1.43%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-66.01%
Return on assets
-135.88%
Return on sales
-331924.38%
Return on invested capital
-71.73%
Total debt ratio
202.97%
Debt ratio change over time
2.03%
Current Ratio
-0.57%
Quick Ratio
-0.22%
Cash Position Ratio
-0.64%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IBRX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 26.22% | 0% | 5.97% | 8.91% |
| Return on assets | -20.96% | 2.97% | 3.34% | 2.04% |
| Return on sales | -119059.3% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | -11.82% | 0% | 3.51% | 10.25% |
| Profitability | 25% | 47% | 64% | 68% |
| Total debt ratio | 240.51% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | 2.03% | 14.34% | 187.33% | 9.75% |
| Dept financing | 25% | 12% | 32% | 6% |
| Current Ratio | 4.3% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 4.19% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 1.61% | 0.39% | 0.58% | 0.86% |
| Liquididy | 75% | 42% | 33% | 50% |
| Short-term ratios | IBRX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -17% | 3.27% | 4.7% | 1.36% |
| Return on sales | -213.64% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 35% | 50% | 18% |
| Total debt ratio | 234.35% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 10% | 7% | 4% |
| Current Ratio | 4.3% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 4.19% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 1.61% | 0.39% | 0.58% | 0.86% |
| Liquididy | 75% | 19% | 25% | 37% |